|
Index of reports
> Cases resulting in death (34)
> Cases with Ovarian Cancer Metastatic (8)
Below is the selection of adverse event reports related to Premarin (Conjugated Estrogens) that includes cases resulting in death where reactions include ovarian cancer metastatic.
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female, weighing 79.5 kg (174.8 pounds)
Adverse reactions / side effects: Ovarian Cancer Metastatic
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Premarin
Dosage: unspecified
Administration route: Oral
Start date: 1992-01-01
End date: 2004-01-01
Estrogens Esterified / Methyltestosterone
Estrace
Estradiol
Dosage: unknown
Administration route: Oral
Indication: Menopausal Symptoms Prophylaxis
Start date: 1989-01-01
Other drugs received by patient: Xanax
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: female, weighing 103.4 kg (227.5 pounds)
Adverse reactions / side effects: Ovarian Cancer Metastatic
Adverse event resulted in: death
Suspect drug(s):
Prempro
Premarin
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a lawyer from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Ovarian Cancer Metastatic
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Premarin
Indication: Oestrogen Replacement Therapy
Medroxyprogesterone Acetate
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-02
Patient: female
Adverse reactions / side effects: Ovarian Cancer Metastatic, Pulmonary Embolism
Adverse event resulted in: death
Suspect drug(s):
Prempro
Premarin
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-02
Patient: female
Adverse reactions / side effects: Ovarian Cancer Metastatic
Adverse event resulted in: death
Suspect drug(s):
Premarin
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Start date: 1997-01-01
End date: 1999-11-16
Provera
Dosage: unknown
Indication: Hormone Replacement Therapy
Start date: 1997-01-01
End date: 1999-11-16
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-06-12
Patient: female
Adverse reactions / side effects: Ovarian Cancer Metastatic
Adverse event resulted in: death
Suspect drug(s):
Premarin
Dosage: unknown
Administration route: Oral
Start date: 1983-01-01
End date: 2002-11-27
Medroxyprogesterone
Dosage: unknown
Administration route: Oral
Start date: 1983-01-01
End date: 2002-11-27
Prempro
Dosage: unknown
Administration route: Oral
Start date: 1996-01-01
End date: 1996-01-01
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-04-18
Patient: female
Adverse reactions / side effects: Ovarian Cancer Metastatic
Adverse event resulted in: death
Suspect drug(s):
Premarin (Conjugated Estrogens)
Adverse event in receiving Premarin (Conjugated Estrogens)
Reported by a lawyer from United States on 2007-02-06
Patient:
Adverse reactions / side effects: Ovarian Cancer Metastatic
Adverse event resulted in: death
Suspect drug(s):
Premarin (Conjugated Estrogens)
|
